JBT MAREL Corp

JBTM

NYSEMid CapIndustrials

13F Pro Quality Score

64.3/100

Rank #557 of 2,962 stocksTOP 25%

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

94.2/100

Profitability

63.1/100

Balance Sheet

55.6/100

Earnings Quality

74.6/100

Free Cash Flow

50.3/100

Institutional Flow

6.9/100

Revenue Scale

74.3/100

Dilution Risk

70.6/100

Price Chart

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

What's Driving JBTM's Business? Latest 10-Q Breakdown

22/22 datapoints verified

AI-extracted from the 10-Q filed 2026-08-05 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenue rose 4.9% YoY to $981M as Protein Solutions grew 10.9% on poultry demand, while net income jumped to $28M despite a $33M intangible impairment and unremediated Marel material weaknesses.

Biggest Revenue Drivers

Prepared Food and Beverage Solutions$514M0% YoY (flat)

Organic revenue declined on lower equipment volumes across certain end markets, offset by $8M favorable FX translation.

Protein Solutions$467M+10.9% YoY

Organic growth driven by higher recurring revenue and a recovery in non-recurring project activity within poultry end markets; $11M from favorable currency translation.

Biggest Revenue Drivers

Total revenue: $981M+4.9% YoY

Prepared Food and Beverage Solutions$514M0% YoY (flat)

Organic revenue declined on lower equipment volumes across certain end markets, offset by $8M favorable FX translation.

Protein Solutions$467M+10.9% YoY

Organic growth driven by higher recurring revenue and a recovery in non-recurring project activity within poultry end markets; $11M from favorable currency translation.

Largest Expense Items

Cost of sales$622M-3.7% YoY (unfavorable)

Rose with higher sales volumes, though gross margin still improved on favorable net tariff impact and improved fixed-cost leverage.

Selling, general and administrative expense$313M-9.1% YoY (unfavorable)

Primarily driven by a one-time $33M intangible asset impairment charge, partially offset by lower acquisition-related depreciation and amortization.

Interest expense, net$13M+55.2% YoY (favorable)

Decreased due to benefits from net investment hedges executed in Q2/Q3 2025 and lower average debt balances.

Margins: Gross profit margin rose 80 bps to 36.6%, aided by a 62 bps net tariff benefit, higher sales volume, and improved fixed-cost leverage, partly offset by inflationary costs; SG&A as a percentage of revenue rose 120 bps to 31.9% due to the one-time impairment charge.

Watch Items from the Filing

Disclosure controls were concluded not effective as of June 30, 2026 due to unremediated Marel material weaknesses in IT general controls and journal entry review.
$33 million non-cash impairment charge recorded on Protein Solutions customer relationship and technology intangibles due to updated business forecasts.
Prepared Food and Beverage Solutions Adjusted EBITDA margin fell 70 bps to 17.5% on productivity inefficiencies tied to manufacturing footprint and supply chain optimization.
$1.5 billion of remaining performance obligations expected to convert to revenue, with 60%-70% recognized during 2026, supporting full-year growth guidance.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →